| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |